Use access key #2 to skip to page content.

portefeuille (99.67)

biopharmaceuticals CRME

Recs

5

April 19, 2010 – Comments (9)

---------------

January 13, 2010

I have mentioned CRME a few times (see this and the comment section of this post). If you have CRME shares you might want to consider selling some of those.

---------------

(from here)

 

It may be time to sell a second tranche ... 

9 Comments – Post Your Own

#1) On April 19, 2010 at 12:41 PM, portefeuille (99.67) wrote:



enlarge

 



enlarge

Report this comment
#2) On April 19, 2010 at 12:48 PM, portefeuille (99.67) wrote:

March 24th, 2010, Barclays Capital 2010 Global Healthcare Conference

Report this comment
#3) On April 19, 2010 at 1:38 PM, portefeuille (99.67) wrote:

and do keep at least 50% of you shares or buy a few if you don't have any, hehe ...

Report this comment
#4) On April 19, 2010 at 1:40 PM, portefeuille (99.67) wrote:

you shares

your shares

Report this comment
#5) On April 19, 2010 at 2:22 PM, NYCFOOLIO (< 20) wrote:

hahah..what to do...already took profits lil while back...so i guess i will keep the rest...

what is reason for your suggestion to sell some?  and then to buy? haha

Report this comment
#6) On April 19, 2010 at 2:28 PM, portefeuille (99.67) wrote:

I just think that a little profit taking might be a good idea. I do recommend being "overweight" CRME, so the advice to buy some was for the ones that are "underweighted".

Report this comment
#7) On April 19, 2010 at 10:07 PM, NYCFOOLIO (< 20) wrote:

sounds good...thanks

Report this comment
#8) On June 25, 2010 at 11:07 AM, portefeuille (99.67) wrote:

Investigational BRINAVESS (vernakalant) for Infusion Recommended for Approval by the CHMP in the European Union (EU) for the Rapid Conversion of Recent Onset Atrial Fibrillation

Report this comment
#9) On September 02, 2010 at 12:37 AM, portefeuille (99.67) wrote:

BRINAVESS (vernakalant) for Infusion Approved in the European Union for Rapid Conversion of Recent Onset Atrial Fibrillation

Report this comment

Featured Broker Partners


Advertisement